We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$729M
AUM Growth
+$56.4M
Cap. Flow
+$52.1M
Cap. Flow %
7.15%
Top 10 Hldgs %
68%
Holding
32
New
8
Increased
10
Reduced
8
Closed
6

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$34.5M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$31.7M
3
AKRX
Akorn Inc
AKRX
+$23.7M
4
TVTX icon
Travere Therapeutics
TVTX
+$18.1M
5
RLYP
RELYPSA INC COM
RLYP
+$16M

Top Sells

Rank Stock Value
1
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$37.6M
2
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$25.3M
3
MYGN icon
Myriad Genetics
MYGN
+$19.8M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$15.8M
5
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 67.96%
2 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-630,178
Closed -$9.45M
MYGN icon
27
Myriad Genetics
MYGN
$270M
– –
-507,682
Closed -$19.8M
SUPN icon
28
Supernus Pharmaceuticals
SUPN
$2.59B
– –
-1,440,008
Closed -$15.8M
WX
29
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
– –
-1,143,315
Closed -$37.6M
IPCM
30
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
– –
-573,209
Closed -$25.3M
FURX
31
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
– –
-13,440
Closed -$1.43M
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Consonance Capital Management held 32 positions worth $729M, up 8.4% from $672M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Consonance Capital Management deployed $52.1M of net new capital in Q3 2014, opening 8 new positions and adding to 10 existing holdings. Its largest new stake was AUXILIUM PHARAMCEUTICALS INC: 1,493,560 shares worth $44.6M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 74% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Taro Pharmaceutical Industries Ltd., an estimated $10.1M trimmed.

  • Consonance Capital Management's largest Q3 2014 buy was AUXILIUM PHARAMCEUTICALS INC: 1,493,560 shares worth $44.6M.
  • Consonance Capital Management added most to United Therapeutics in Q3 2014, an estimated $34.5M increase.
  • Consonance Capital Management's biggest Q3 2014 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $10.1M.
  • Consonance Capital Management fully exited WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014, selling an estimated $37.6M.
  • Consonance Capital Management's ten largest holdings make up 68% of its $729M portfolio in Q3 2014.
  • Consonance Capital Management opened 8 new positions and closed 6 in Q3 2014.
  • Consonance Capital Management's portfolio value rose 8.4% quarter-over-quarter to $729M.

Based on Consonance Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.